BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 3686342)

  • 21. [Imaging of adrenal glands].
    Hoeffel C; Tenenbaum F; Bonnin A; Richard B
    Rev Prat; 1998 Apr; 48(7):718-23. PubMed ID: 11767365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
    Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
    Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
    Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
    AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
    Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
    AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies.
    Krestin GP; Steinbrich W; Friedmann G
    Radiology; 1989 Jun; 171(3):675-80. PubMed ID: 2717737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.
    Koo HJ; Choi HJ; Kim HJ; Kim SO; Cho KS
    Eur Radiol; 2014 Jun; 24(6):1410-20. PubMed ID: 24647823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic imaging in the evaluation of adrenal masses].
    Gualdi GF; Di Biasi C; Caterino M; Polettini E; Pingi A; Trasimeni G
    Clin Ter; 1988 Feb; 124(3):233-8. PubMed ID: 2974337
    [No Abstract]   [Full Text] [Related]  

  • 28. Is computed tomography guided biopsy still necessary for the diagnosis of adrenal masses in patients with resectable non-small-cell lung cancer?
    Porte HL; Ernst OJ; Delebecq T; Métois D; Lemaitre LG; Wurtz AJ
    Eur J Cardiothorac Surg; 1999 May; 15(5):597-601. PubMed ID: 10386403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenal masses: differentiation with chemical shift, fast low-angle shot MR imaging.
    Tsushima Y; Ishizaka H; Matsumoto M
    Radiology; 1993 Mar; 186(3):705-9. PubMed ID: 8430178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
    Woo S; Cho JY; Kim SY; Kim SH
    Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Imaging methods in diagnosis of pheochromocytoma].
    Neumann K; Langer R
    Zentralbl Chir; 1997; 122(6):438-42. PubMed ID: 9334109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinction between adrenal adenomas and metastases using MR imaging.
    Reinig JW; Doppman JL; Dwyer AJ; Johnson AR; Knop RH
    J Comput Assist Tomogr; 1985; 9(5):898-901. PubMed ID: 4031166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT and MR distinction of adenomas and nonadenomas of the adrenal gland.
    van Erkel AR; van Gils AP; Lequin M; Kruitwagen C; Bloem JL; Falke TH
    J Comput Assist Tomogr; 1994; 18(3):432-8. PubMed ID: 8188912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Adrenal gland metastasis of clear-cell renal cell carcinoma: a diagnostic problem in chemical-shift MRT imaging].
    Kreft B; Zhou H; Albers P
    Rofo; 2003 Sep; 175(9):1275-7. PubMed ID: 12964087
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
    Haider MA; Ghai S; Jhaveri K; Lockwood G
    Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the T2-weighted (T2W) adrenal MRI calculator to differentiate adrenal pheochromocytoma from lipid-poor adrenal adenoma.
    Gerson R; Tu W; Abreu-Gomez J; Udare A; McPhedran R; Ramsay T; Schieda N
    Eur Radiol; 2022 Dec; 32(12):8247-8255. PubMed ID: 35680653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current status of imaging for adrenal gland tumors.
    Song JH; Mayo-Smith WW
    Surg Oncol Clin N Am; 2014 Oct; 23(4):847-61. PubMed ID: 25246052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement characteristics of pheochromocytomas.
    Happel B; Heinz-Peer G
    Radiology; 2006 Jan; 238(1):373; author reply 373-4. PubMed ID: 16373781
    [No Abstract]   [Full Text] [Related]  

  • 39. [Distinction between adrenal adenomas and metastases using 0.5 Telsa MR imaging: diagnosis with out-of-phase T2*-weighted gradient-field-echo image].
    Ichikawa T; Fujimoto H; Uchiyama G; Murakami K; Ohtomo K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):229-34. PubMed ID: 8177696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of adrenal and extra-adrenal pheochromocytomas by magnetic resonance imaging.
    Beland SS; Vesely DL; Arnold WC; Beavers HK; Gilbert SR; Henson GN; Williamson MR
    South Med J; 1989 Nov; 82(11):1410-3. PubMed ID: 2683130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.